FlowCardia

Developing endovascular devices for chronic total occlusion (CTO) recanalization

FlowCardia was a medical device company focusing on developing and marketing products for the treatment of coronary and peripheral CTO. The company’s CROSSER CTO recanalization catheter, steerable support catheters, and porter guidewires enable physicians to quickly cross CTOs allowing for subsequent angioplasty, artherectomy, and/or stent placement. FlowCardia was acquired by C.R. Bard in 2010.

Status

Acquired by C.R. Bard in 2010

Year of Investment

2002

Strategy

Other

Location

Sunnyvale, California

Frazier Team